Health ❯ Healthcare ❯ Medical Research

Clinical Trials

Cancer Treatment Immunotherapy Alzheimer's Disease Innovative Treatments Breast Cancer Transplantation Studies Gene Therapy Stem Cell Therapy Patient Outcomes Cancer Vaccines Oncology Colorectal Cancer Hypertension Drug Development Drug Efficacy Cancer Research Gene Editing Breast Cancer Treatment Obesity Treatment Duchenne Muscular Dystrophy Type 1 Diabetes Cancer Treatments Bladder Cancer Prostate Cancer Pediatric Studies Multiple Sclerosis Observational Studies New Treatments Adaptive Deep Brain Stimulation Surgical Techniques Translational Medicine AI Applications in Medicine IgA Nephropathy FDA Approval Dementia Asthma Treatment Phase 3 Trials Study Findings Alzheimer's Treatments Alzheimer's Disease Treatments Transplantation Research Xenotransplantation Studies Multiple Myeloma Efficacy Studies Radiation Therapy Innovative Surgical Techniques Organ Transplants Spinal Cord Injury Lung Cancer Cancer Immunotherapy Parkinson's Disease Systemic Mastocytosis Patient Advocacy NHS App Patient Care Organ Transplantation NIH Treatment Options Bladder Transplant Trials Glioblastoma Treatment Effectiveness Studies Long-term Effects eHealth Solutions Transplant Technology Adenoma Detection Obesity Treatments Erythropoietic Protoporphyria Stroke Treatment Comparative Effectiveness Research Cochrane Reviews FDA Regulations Fatty Liver Disease Neoadjuvant Therapy Ethics in Research Innovative Procedures Ophthalmology Enteral Ventilation Mitochondrial Donation Research Blood Transfusion Safety Retinal Diseases Gene Therapy Trials Long Covid Research Epilepsy Treatment AI in Clinical Trials Innovations Teplizumab Patient Case Studies Animal Testing Randomised Controlled Trials Hereditary Angioedema Acquired Hypothalamic Obesity Transplantation Innovations Aldosterone Synthase Inhibitors Gene Therapy Research AI Impact on Skills Therapeutic Strategies TOPSPIN Study Guideline Development Immunotherapy Advances SENTI-202

Sarepta Reports 3-Year EMBARK Data Showing Elevidys Slows Duchenne Progression

The readout lands under heightened FDA scrutiny following two liver‑failure deaths in non‑ambulatory patients.

Moderna–Merck Personalized Melanoma Vaccine Sustains 5-Year Benefit, Cutting Recurrence Risk by 49%

Cochrane Update Finds No Clear Benefit of Cannabis-Based Medicines for Neuropathic Pain

First Patient to Receive Pig Then Human Kidney Is Recovering at Home

Lilly Reports Zepbound Plus Taltz Beat Taltz Alone in Psoriatic Arthritis Trial

Pooled Data Tie Early AE Management to Greater Zolbetuximab Benefit in Gastric/GEJ Cancer

Sanofi Ends PPMS Bid After Tolebrutinib Fails Phase 3 as FDA Delays Review for nrSPMS

Lilly’s Imlunestrant Data Show Stronger Results With Abemaciclib, Delayed Chemotherapy in ER+ Breast Cancer

15-Minute HCV RNA Test Validated With 100% Agreement in Johns Hopkins Study

Preoperative MRI Fails to Improve Outcomes in Early HR-Negative Breast Cancer

Tucatinib Added to First-Line HER2 Maintenance Prolongs Progression-Free Survival in Phase 3 Trial

Roche’s Giredestrant Cuts Early Breast Cancer Recurrence 30% in Phase III Trial

Teclistamab–Daratumumab Delivers Major Survival Gains in Relapsed Myeloma, Phase 3 Data Show

Ianalumab Plus Eltrombopag Extends Disease Control in Phase 3 ITP Study Published in NEJM

Epcoritamab Added to R2 Yields Large Efficacy Gains in Relapsed Follicular Lymphoma

Shorter, Chemo-Free Strategies Match or Beat Standard Care in Adult Leukemias at ASH

EndRAD Phase 2 Finds Non-TBI Conditioning Matches Outcomes in MRD-Negative Young B-ALL

Early Cilta-Cel Use Linked to Better Outcomes in Relapsed/Refractory Myeloma, ASH 2025 Data Show

Exa‑cel Posts Complete Primary-End Point Responses in Early Pediatric Trials, With One Fatal Busulfan Event

Pliant’s PLN-101095 With Keytruda Shows Early Responses in PD-1–Refractory Solid Tumors